Found a Breast Lump | What Happens Next, and How Fast

TL;DR30-second take

Most breast lumps turn out to be something other than cancer, and a new lump needs prompt evaluation rather than watchful waiting. A lump you can feel requires diagnostic imaging: targeted ultrasound under 30, diagnostic mammography plus ultrasound at 30 and older. Fishtown Medicine orders that imaging directly, and a lump that persists after normal imaging still warrants tissue sampling.

TL;DR: Most breast lumps turn out to be something other than cancer. That is true, and it is also not a reason to wait and see at home. A new lump needs to be looked at with imaging, and the right first test depends on your age. Under 30, that usually means a breast ultrasound. At 30 and over, it means a diagnostic mammogram plus an ultrasound. A diagnostic mammogram is a different order from a screening mammogram, and a lump you can feel needs the diagnostic kind, so say the words "new breast lump" when you call. If the pictures come back normal but the lump is still there, that is not the end of it. Ask about a biopsy. And if the office you called has not called you back, you do not have to keep calling the same number. Any physician can order the imaging, and a new one can order it without redoing your whole history first.

Is a breast lump usually cancer?

Most breast lumps are not cancer, and the numbers behind that are better than most people expect. In a study of 10,830 women referred to a breast diagnostic clinic in the UK, about 5% of the women referred with a lump turned out to have breast cancer, which means roughly 19 out of 20 did not (Dave et al., British Journal of General Practice, 2022). United States figures point the same way: the Breast Cancer Surveillance Consortium's national benchmark for diagnostic mammograms done to evaluate a lump found about 64.5 cancers per 1,000 exams, a little under 7% (Sprague et al., Radiology, 2017). Cysts and fibroadenomas account for a large share of what those workups find instead.

That reassurance needs one more sentence beside it. Those odds are good because people go in and get the lump named, and the reassurance is earned by the workup rather than assumed from the statistics. Nobody can tell from the outside which lump belongs to the 19 and which belongs to the 1. The point of the next few weeks is to move you from a probability to an answer.

If you have already called somewhere about this and heard nothing back, that silence is not information about how serious your lump is. It is information about a phone system. The rest of this page is written so you know what you are asking for and can ask for it somewhere else.

Which features make a breast lump more concerning?

Certain features of a breast lump raise the level of concern, and knowing them helps you describe what you found in a way that gets the right appointment booked.

A lump that is growing. Change over weeks is one of the strongest reasons to move quickly, and a lump that is bigger than it was a month ago belongs in a diagnostic pathway now.
Hard, irregular, and fixed. Cancers more often feel firm to hard, with poorly defined or irregular edges, and they tend to be anchored to the tissue around them rather than sliding under your fingers.
Painless. This one surprises people, because pain feels like the alarm bell. It works the other way around here. A breast cancer that shows up as a lump is usually a painless lump, and in that same UK cohort of 10,830 women, the group referred for breast pain alone had a 0.4% cancer rate against roughly 5% among the women referred with a lump. Pain does not make a lump safe, and the absence of pain is a reason to take it more seriously.
Skin changes over the lump. Dimpling, puckering, a thickened patch, or skin that has taken on an orange-peel texture. Redness and warmth across a large part of one breast is its own urgent picture and needs to be seen right away.
Nipple changes. A nipple that has newly turned inward or become retracted, or scaling and crusting of the nipple skin that does not settle.
Nipple discharge with specific features. Discharge that is bloody or clear, comes out on its own without squeezing, comes from one breast, and comes from a single opening on the nipple is the pattern that gets investigated (ACR Appropriateness Criteria, Evaluation of Nipple Discharge). Milky discharge from both sides is a different question with different causes.
A swollen lymph node in the armpit or above the collarbone alongside the lump. An enlarged node with a breast lump changes the urgency of the workup.

Now the caveat that keeps this honest. Physical findings alone are not accurate enough to sort cancer from everything else, and cancers can feel smooth, soft, and mobile. A lump with none of the features above still gets imaged, and the exam is one input rather than the verdict.

What is the difference between a screening and a diagnostic mammogram?

A screening mammogram and a diagnostic mammogram are 2 different orders, and the difference is the reason a lot of people lose weeks without knowing it.

A screening mammogram is for someone with no breast symptoms. It takes standard views of both breasts, and a radiologist reads it later, often in a batch with other studies. You go home before anyone has looked at it.

A diagnostic mammogram is ordered because of a symptom: a lump you can feel, nipple discharge, a skin change, or an abnormal screening result that needs a closer look. The technologist marks the spot you point to with a small skin marker so the radiologist knows where to look. Extra views and angled views are taken of that area. A radiologist reads the images while you are still there and can add more pictures or move you straight to ultrasound in the same visit.

A lump you can feel belongs in the diagnostic pathway. Booking a screening mammogram for a lump gets you the standard views, a delayed read, and a callback asking you to return and do it properly, which is how 2 weeks turn into 6 without anyone intending it. So the words matter: on the phone, at the front desk, and on the order itself, this is a diagnostic mammogram with targeted ultrasound for a palpable lump. In Philadelphia, many breast imaging centers are set up to do both in the same visit, so it is fair to ask for that when you book.

Which test comes first, and does age change it?

Age changes which imaging test comes first, and the reason is physics rather than preference. Younger breast tissue is dense, dense tissue and tumors both appear white on a mammogram, and ultrasound sees through that far better.

The ACR Appropriateness Criteria for Palpable Breast Masses, 2022 Update sets it out by age:

Under 30, targeted breast ultrasound is the appropriate first imaging test. If the ultrasound looks suspicious, diagnostic mammography or tomosynthesis follows, along with image-guided biopsy.
Ages 30 to 39, either targeted ultrasound or diagnostic mammography is an appropriate starting point, and in practice both are frequently done.
40 and older, diagnostic mammography or digital breast tomosynthesis comes first, with targeted ultrasound to characterize what the mammogram shows or to look at the spot the mammogram calls normal.

The American College of Obstetricians and Gynecologists draws the same line at 30 in Practice Bulletin No. 164: ultrasonography is the preferred first study under 30, and at 30 and older a diagnostic mammogram should be obtained, with ultrasound often required as well.

What that means practically is that at 30 and above, the order your physician writes should ask for both studies at once. Asking for both up front saves a second trip and a second authorization.

What is the triple assessment, and why does it matter here?

The triple assessment, also called the triple test, is the framework that breast clinics use to close the question on a lump, and it has 3 parts: the clinical examination, the imaging, and tissue sampling when the first 2 do not settle it. When all 3 agree, diagnostic accuracy approaches 100% (Morris et al., Archives of Surgery, 1998).

The useful part of that framework is what it says about disagreement. When the exam points in one direction and the imaging points in another, the disagreement itself is the finding, and it is what drives the next step rather than something to average out. A lump that feels suspicious with reassuring pictures does not get filed as reassuring. It gets tissue.

Tissue sampling today usually means a core needle biopsy done under ultrasound guidance with local anesthetic, which takes a small cylinder of the tissue for a pathologist to read. Fine needle aspiration still has a role, particularly for draining a cyst or sampling an abnormal lymph node. Open surgical biopsy has become the exception rather than the starting point.

What if the mammogram is normal but the lump is still there?

A normal mammogram does not close the question when you can still feel a lump, and this is the most important safety point on this page. The ACR states it plainly in its criteria for palpable breast masses: a negative imaging evaluation should never overrule a suspicious finding on physical examination.

The reason is that mammography misses some cancers you can feel. In the setting of a palpable mass, the false negative rate for mammography alone has been estimated in the range of 4% to 12%, and the overall false negative rate of mammography is often cited near 15%. Adding ultrasound closes most of that gap. Across published series, the negative predictive value of mammography combined with ultrasound for a palpable mass runs from about 97.4% to 100%, and one study of women presenting with palpable masses found a negative predictive value of 99.7% when combined imaging read as normal (Chan et al., Breast Cancer Research and Treatment, 2015).

A negative predictive value of 99.7% is very good, and it is still not zero. So the rule that protects you is this one: if the lump persists, if it grows, or if the exam is worrying, the next step is tissue rather than another interval of waiting. Two practical things to ask before you leave the imaging center are which BI-RADS category was assigned to your study, and what the plan is if the lump is still there in 6 to 8 weeks. Both answers should be available to you, and if you leave without them, asking again is a reasonable thing to do.

What do dense breasts change?

Dense breast tissue lowers how much a mammogram can see, which is why it changes the plan when there is a lump to evaluate. Density describes how much of the breast is fibroglandular tissue versus fat. On a mammogram, dense tissue appears white and so does a tumor, so a cancer in a dense breast can hide the way a snowball hides in snow.

Get Real Answers

Tired of being told your labs are 'normal'? Dr. Ash digs deeper.

Start Your Investigation

The size of that effect is substantial. In an analysis of 27,825 screening evaluations, mammographic sensitivity was about 98% in fatty breasts and about 48% in the densest breasts, while mammography and ultrasound together reached about 97% sensitivity across the dense categories (Kolb et al., Radiology, 2002).

Since September 10, 2024, the FDA has required every mammography facility in the United States to tell you in your results whether your breasts are dense, using standard national language stating that dense tissue makes breast cancer harder to find on a mammogram and also raises the risk of developing it (FDA, MQSA Final Rule). If a prior report told you your breasts are dense, bring that up when you book, because it is a further reason the ultrasound belongs next to the mammogram rather than after it.

How fast should a new breast lump be evaluated?

The honest answer is that guidance varies, and no major United States guideline publishes a number of days for this. The ACR and ACOG documents describe which test and in what order, without setting a clock. I would rather tell you that than invent a deadline.

Two things do give the question shape. The first is that the UK does publish a timeframe: NICE guideline NG12 directs that anyone 30 or over with an unexplained breast lump, with or without pain, be referred on a suspected cancer pathway for an appointment within 2 weeks, and that a non-urgent referral be considered under 30. The second is what the delay literature shows: a systematic review in The Lancet found that delays of 3 months or more between the onset of symptoms and treatment were associated with more advanced stage and lower survival (Richards et al., The Lancet, 1999).

Put together, the working answer is days to a couple of weeks, and the 3-month mark is where the evidence starts to argue with you. If you are 2 weeks past finding it with no imaging appointment on the calendar, that is the moment to change something rather than wait longer. What to change is the next section.

What if your doctor's office is not calling you back?

When a practice is not returning your calls, the fix is to route the request somewhere it will be seen rather than to keep dialing the same number. Offices get overwhelmed and messages fall through in ways that have very little to do with how much anyone there cares, and none of that changes what your lump needs. Here is what tends to work.

Put it in writing. A patient portal message or an email creates a dated record and usually arrives in a different queue than the phone line. Lead with the clinical facts in the first line: a new breast lump, which side, how long it has been there, whether it is growing, and the date of your last mammogram. Then ask for one specific thing, named clearly enough to act on, such as an order for a diagnostic mammogram with targeted ultrasound of the affected breast, sent to a named imaging center, with a copy sent to you.

Ask for your records in writing too. Under HIPAA's right of access, a practice must act on your request for your own records within 30 days, with a single 30-day extension that has to be explained to you in writing (HHS, 45 CFR 164.524). A written request starts that clock in a way a voicemail does not. Ask for the report and the images from your last mammogram, since prior images give the radiologist a comparison.

Know that a new physician can order the imaging without repeating everything. A diagnostic mammogram needs a physician's order, and any licensed physician can write it. Getting that order does not require transferring your whole chart first, and it does not require waiting for old records to arrive. The imaging can be ordered now and the records can follow.

Confirm the order arrived. Call the imaging center yourself and ask whether they have it and what it says. Orders get lost between a fax machine and a front desk more often than anyone would like, and 1 phone call to the right place saves a week.

Keep the appointment even if the lump seems smaller. Lumps that come and go with your cycle are common and usually reassuring, and that is a finding for the radiologist and your physician to confirm rather than a reason to cancel.

Can men get breast lumps that need this workup?

Men get breast cancer, and a breast lump in a man goes down the same evaluation pathway. About 1% of all breast cancers in the United States occur in men, and the average lifetime risk for a man is roughly 1 in 755 (American Cancer Society). Male breast cancer typically shows up as a firm, painless mass, often under or beside the nipple, sometimes with nipple retraction or discharge.

Gynecomastia, meaning noncancerous enlargement of male breast tissue, is far more common than cancer and usually feels like soft, rubbery tissue spread symmetrically behind both nipples. A hard, one-sided, off-center mass is a different finding and gets imaged. The ACR criteria for the symptomatic male breast start with ultrasound for men under 25 with an indeterminate palpable mass, and with mammography for men 25 and older or for any man whose exam is suspicious for cancer, adding ultrasound as needed.

A male breast lump gets the same order as any other breast lump here, because the pathway does not change with sex, and the exam features listed earlier on this page carry the same weight.

Guidance from the Clinic

"The thing I want people to hear is that most breast lumps turn out to be something other than cancer, and that you get to that answer by having it imaged rather than by watching it at home. When someone tells me a lump has been there for weeks and is getting bigger, my whole job that day is to get a diagnostic mammogram and an ultrasound on the calendar and to make sure the order arrives where it needs to go. And if the mammogram comes back normal while I can still feel the lump, we keep going. A picture that disagrees with my hand does not win."

What to do this week

A short list, in order.

Write down what you found. Which breast, roughly where, how long it has been there, whether it has changed, and the date of your last mammogram. Photograph any skin or nipple change in the same light each time.
Ask for the study by name. At 30 and over: a diagnostic mammogram with targeted ultrasound for a palpable lump. Under 30: a targeted breast ultrasound. Saying "diagnostic" at the front desk is what keeps you out of the screening queue.
Send the request in writing. A portal message or an email with the clinical facts in the first line and one specific ask: the order, the imaging center, and a copy to you.
Call the imaging center yourself to confirm the order arrived and to ask whether the mammogram and ultrasound can be done in the same visit.
Ask what happens if the imaging is normal. Get the BI-RADS category and a written plan for the lump if it is still there in 6 to 8 weeks.
If nobody has called you back, ask someone else. Tell Dr. Ash what is going on with which breast, how long, and whether it is growing, and the imaging can be ordered without redoing your whole history first.

Key Takeaways

Most breast lumps are not cancer, with roughly 5% of women referred with a lump turning out to have breast cancer, and that reassurance comes from completing the workup rather than from waiting at home.
The features that raise concern are a growing lump, a hard or fixed or irregular lump, a painless lump, skin dimpling or thickening, new nipple retraction, bloody or spontaneous single-duct nipple discharge, and an enlarged node in the armpit.
A lump you can feel requires a diagnostic mammogram rather than a screening one, and the diagnostic study is read while you are there so ultrasound can be added in the same visit.
Under 30, targeted ultrasound comes first; at 30 and over, diagnostic mammography plus targeted ultrasound is the standard pairing.
A normal mammogram does not close the question when a lump is still palpable, since negative imaging should never overrule a suspicious exam, and tissue sampling is the next step.
Dense breast tissue cuts mammographic sensitivity from about 98% to about 48%, which is why ultrasound belongs alongside the mammogram.
Men get breast cancer and a male breast lump follows the same pathway, with ultrasound first under 25 and mammography first at 25 and over.
If a practice is not returning calls, put the request in writing, name the study and the imaging center, request records under HIPAA's 30-day rule, and ask a different physician to write the order.

When Your Practice Stops Calling Back - getting records, orders, and appointments moving again
Swollen Lymph Nodes: When to Watch and When to Act - how to read a node in the armpit or neck
The Neck Lump That Comes and Goes - why a lump that fluctuates behaves differently
When You Need an Ultrasound, Body Part by Body Part - what ultrasound answers and what it cannot
When to Order Imaging - how we decide what is worth scanning
Managing Labs and Imaging with Ease - getting studies scheduled around Philadelphia
Catching It Early: Advanced Screening - screening beyond the standard schedule

Scientific References

Expert Panel on Breast Imaging; Klein KA, Kocher M, et al. "ACR Appropriateness Criteria: Palpable Breast Masses: 2022 Update." Journal of the American College of Radiology. 2023;20(5S):S146-S163. ScienceDirect
American College of Obstetricians and Gynecologists. "Practice Bulletin No. 164: Diagnosis and Management of Benign Breast Disorders." Obstetrics & Gynecology. 2016;127(6):e141-e156. ACOG
Dave RV, Bromley H, Taxiarchi VP, et al. "No association between breast pain and breast cancer: a prospective cohort study of 10,830 symptomatic women presenting to a breast cancer diagnostic clinic." British Journal of General Practice. 2022;72(717):e234-e243. BJGP / PubMed
Morris A, Pommier RF, Schmidt WA, et al. "Accurate Evaluation of Palpable Breast Masses by the Triple Test Score." Archives of Surgery. 1998;133(9):930-934. JAMA Network
Chan CH, Coopey SB, Freer PE, Hughes KS. "False-negative rate of combined mammography and ultrasound for women with palpable breast masses." Breast Cancer Research and Treatment. 2015;153(3):699-702. Springer
Kolb TM, Lichy J, Newhouse JH. "Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors That Influence Them: An Analysis of 27,825 Patient Evaluations." Radiology. 2002;225(1):165-175. RSNA
Sprague BL, Arao RF, Miglioretti DL, et al. "National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium." Radiology. 2017;283(1):59-69. RSNA
Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. "Influence of delay on survival in patients with breast cancer: a systematic review." The Lancet. 1999;353(9159):1119-1126. The Lancet
National Institute for Health and Care Excellence. "Suspected cancer: recognition and referral (NG12), breast cancer recommendations." NICE
Expert Panel on Breast Imaging. "ACR Appropriateness Criteria: Evaluation of Nipple Discharge, 2022 Update." Journal of the American College of Radiology. ScienceDirect
Expert Panel on Breast Imaging. "ACR Appropriateness Criteria: Evaluation of the Symptomatic Male Breast." ACR Appropriateness Criteria
US Food and Drug Administration. "Important Information: Final Rule to Amend the Mammography Quality Standards Act (MQSA)." FDA
American Cancer Society. "Breast Cancer Signs and Symptoms." Cancer.org
American Cancer Society. "Key Statistics for Breast Cancer in Men." Cancer.org
US Department of Health and Human Services. "Individuals' Right under HIPAA to Access their Health Information, 45 CFR 164.524." HHS.gov

Fishtown Medicine | Symptoms

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

Most breast lumps are not cancer. Among 10,830 women referred to a breast diagnostic clinic, about 5% of those referred with a lump had breast cancer, and the United States benchmark for diagnostic mammograms done to evaluate a lump finds about 64.5 cancers per 1,000 exams. Cysts and fibroadenomas account for much of the rest. Those odds hold because lumps get evaluated, so a new lump still needs imaging rather than watchful waiting at home.

A screening mammogram is for people with no breast symptoms and uses standard views read later, while a diagnostic mammogram is ordered for a symptom such as a lump, uses extra and angled views of the marked area, and is read by a radiologist while the patient is still there so more images or an ultrasound can be added on the spot. A lump you can feel requires the diagnostic pathway. Booking a screening study for a lump usually results in a callback to return and repeat it correctly.

No. A painless breast lump is more concerning than a painful one, which surprises most people. A breast cancer that shows up as a lump is usually a painless lump, and in a prospective study of 10,830 symptomatic women, those referred for breast pain alone had a 0.4% cancer rate against roughly 5% among those referred with a lump. Pain is not a reassuring sign and its absence is not a reason to wait.

Possibly yes. The American College of Radiology states that a negative imaging evaluation should never overrule a suspicious finding on physical examination. Combined mammography and ultrasound has a negative predictive value between about 97.4% and 100% for a palpable mass, which is reassuring but not absolute. A lump that persists, grows, or feels suspicious on exam should proceed to tissue sampling, usually a core needle biopsy under ultrasound guidance.

No major United States guideline publishes a specific number of days for evaluating a new breast lump, so the honest answer is that guidance varies. The UK's NICE guideline NG12 directs that anyone 30 or over with an unexplained breast lump be seen on a suspected cancer pathway within 2 weeks. A systematic review in The Lancet found that delays of 3 months or more between symptom onset and treatment were associated with more advanced stage and lower survival. Days to a couple of weeks is the working target.

Dense breast tissue makes cancer harder to see on a mammogram, because dense tissue and tumors both appear white on the image. Mammographic sensitivity was about 98% in fatty breasts and about 48% in the densest breasts in an analysis of 27,825 screening evaluations, while mammography combined with ultrasound reached about 97%. Since September 10, 2024, the FDA has required every United States mammography facility to tell patients whether their breasts are dense.

Deep-Dive Questions

The triple assessment, also called the triple test, evaluates a palpable breast lump using 3 elements: clinical examination, breast imaging, and tissue sampling. When all 3 agree, diagnostic accuracy approaches 100%, which is why concordant results can substitute for open surgical biopsy. When they disagree, the disagreement is the clinically meaningful finding and drives the next step. A lump that feels suspicious with reassuring imaging proceeds to tissue sampling, since the most suspicious element sets the plan rather than the average of the three.

Ultrasound comes first under 30 because younger breasts contain more fibroglandular tissue, which appears white on a mammogram in the same way a tumor does, so mammography loses much of its ability to distinguish them. Ultrasound reads tissue by sound reflection instead and separates a fluid-filled cyst from a mass of tissue regardless of density, and it uses no ionizing radiation. The ACR Appropriateness Criteria therefore make targeted ultrasound the initial study under 30, with diagnostic mammography added when the ultrasound looks suspicious.

BI-RADS, the Breast Imaging Reporting and Data System, is the standardized scale a radiologist assigns to a breast imaging study, and it maps directly onto the next step. Category 0 means the study is incomplete and more imaging is needed before anyone can call it. Category 1 means a negative study and category 2 means a benign finding, and both end imaging follow-up unless the clinical exam disagrees. Category 3 means a probably benign finding that gets short-interval follow-up imaging, usually at 6 months. Categories 4 and 5 indicate suspicion of malignancy and lead to biopsy. Asking which category was assigned to your study turns a vague result into a concrete plan.

A breast lump accompanied by an enlarged axillary lymph node changes the urgency because the lymph nodes under the arm are where breast tissue drains first, so an enlarged node raises the possibility that a process in the breast has already reached them. Infection and inflammation enlarge these nodes far more often than cancer does, and both possibilities are worked up the same way: imaging of the breast and the axilla together, with ultrasound-guided sampling of the node when it looks abnormal. The presence of the node does not diagnose anything on its own, and it does move the evaluation forward in the queue.

Ready when you are